The Neuron: AI Explained

The Neuron

The Neuron is a daily newsletter with 700,000+ readers that covers the latest AI developments, trends and research; this is our podcast, hosted by Grant Harvey and Corey Noles. We aim to create digestible, informative and authoritative takes on AI that get you up to speed and help you become an authority in your own circles. Available Wednesdays and Sundays on all podcasting platforms and YouTube. Subscribe to our newsletter: https://www.theneurondaily.com/subscribe

  1. 3일 전 ·  보너스

    BONUS: Building Real-Time AI Voice Agents with LiveKit's Ben Cherry

    Voice agents are moving from “cool demo” to real product infrastructure. In this livestream, we’re joined by Ben Cherry of LiveKit to break down what it actually takes to build real-time AI agents that can listen, respond, interrupt, call tools, and work in production. LiveKit is an open source framework and developer platform for building voice, video, and physical AI agents in production. We’ll talk through the stack behind real-time AI experiences, then build and test a live demo together on The Neuron. In this live demo, we’ll cover: 🎙️ How LiveKit helps developers build voice, video, and physical AI agents ⚡ What makes real-time agents different from normal chatbots 🧠 How voice agents handle latency, interruptions, speech, and tool calls 🛠️ Why production-ready AI agents are much harder than a weekend demo 🚀 What builders should know before shipping voice AI to real users And yes, we’re doing a live demo, which means there is at least a small chance the agent talks back at exactly the wrong time. Perfect television. Guest: Ben Cherry, LiveKit LiveKit: https://livekit.com/ Ben on LinkedIn: https://www.linkedin.com/in/bcherry-product-engineer Ben on GitHub: https://github.com/bcherry Subscribe to The Neuron for clear, useful AI news, demos, and explainers for people trying to understand where this tech is actually going. https://www.theneuron.ai/

    1시간 9분
  2. 5월 15일 ·  보너스

    BONUS: Can AI Actually Be Your Therapist? We Ask the CEO Building One

    May is Mental Health Awareness Month, and as AI becomes more embedded in our daily lives, one of the biggest questions we face is whether these systems can responsibly support emotional and psychological well-being. AI chatbots are increasingly being used for emotional support, but recent lawsuits faced by OpenAI and earlier ones targeting character.ai and Google's AI Overviews, as well as clinical reports, and internal research have raised valid concerns about their impact on vulnerable users. What does it take to build an AI system specifically designed for mental health from the ground up? Is that even possible? In this LIVE episode of The Neuron Podcast, Corey Noles and Grant Harvey speak with Daniel Reid Cahn, co-founder and CEO of Slingshot AI, about Ash, an AI application purpose-built for therapeutic support. Slingshot has raised $93M from a16z, Radical Ventures, and others to develop a foundation model for psychology trained on structured therapeutic conversations across modalities such as CBT, DBT, and psychodynamic therapy. We discuss the limitations of general-purpose chatbots in mental health contexts, recent controversies surrounding AI and psychiatric risk, and what differentiates a system designed to provide structured therapeutic engagement compared to one being used in a way it was never intended to be. The conversation also explores a broader question: Can AI meaningfully expand access to high-quality mental health care, and where should clear boundaries remain? Or should we keep our counseling where we always have, on a couch with a box of Kleenex and a hug nearby? 🔗 Try Ash: https://www.talktoash.com/ 📌 About The Neuron Podcast The Neuron breaks down the biggest stories in AI for 580,000+ daily readers. Our podcast goes deeper with the leaders, founders, and researchers shaping the future of AI. New episodes every week. Subscribe to The Neuron newsletter — theneuron.ai

    1시간 14분
  3. 5월 6일

    Can AI Really Design New Drugs? Google DeepMind Spin-out Isomorphic Labs Explains

    Can AI move from predicting proteins to actually designing new drugs? Isomorphic Labs is trying to answer one of the biggest questions in science. In this episode of The Neuron, Corey Noles and Grant Harvey talk with Rebecca Paul, Head of Medicinal Drug Design at Isomorphic Labs, and Michael Schaarschmidt, Foundational AI Research Lead. They explain why drug discovery is so slow, expensive, and failure-prone—and why AI drug design is much more complicated than “generate a molecule and ship it.” The conversation covers AlphaFold, structure prediction, molecule generation, binding models, clinical failure rates, human trust in AI systems, and the long-term hope of designing drugs for targets once considered “undruggable.” In this episode: Why drug discovery can take more than a decadeWhat people misunderstand about “AI-designed drugs”How medicinal chemists actually use AI modelsWhy biology is harder than text, images, or codeWhat it would take to make drug discovery faster and cheaperThe dream of designing a drug candidate in one iterationWhy “undruggable” proteins may not stay undruggable forever Additional resources: Technical report blog Best resource for learning about the capabilities that we are buildingIsomorphic Labs websiteBest destination for learning more about Iso and joining our team in London, Lausanne or Cambridge, MA Subscribe for more grounded conversations on how AI is changing science, work, and the world. For more practical, grounded conversations on AI systems that actually work, subscribe to The Neuron newsletter at https://theneuron.ai.

    42분

소개

The Neuron is a daily newsletter with 700,000+ readers that covers the latest AI developments, trends and research; this is our podcast, hosted by Grant Harvey and Corey Noles. We aim to create digestible, informative and authoritative takes on AI that get you up to speed and help you become an authority in your own circles. Available Wednesdays and Sundays on all podcasting platforms and YouTube. Subscribe to our newsletter: https://www.theneurondaily.com/subscribe

좋아할 만한 다른 항목